Last update 21 Nov 2024

Vapitadine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hivenyl, Vapitadine, Vapitadine dihydrochloride
+ [2]
Target
H1 receptor
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists)
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Chronic UrticariaDermatitis, AtopicPruritus
Originator Organization
Johnson & JohnsonJohnson & Johnson
Active Organization-
Inactive Organization
GSK PlcGSK PlcJohnson & JohnsonJohnson & JohnsonStiefel Laboratories, Inc.Stiefel Laboratories, Inc.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H22Cl2N4O
InChIKeyBOYLPLUVCXUHDJ-UHFFFAOYSA-N
CAS Registry279253-83-7
View All Structures (2)

Related

2
Clinical Trials associated with Vapitadine Hydrochloride
EUCTR2005-002749-38-NL / Not yet recruitingNot Applicable
A randomized, double-blind, placebo-controlled exploratory trial to evaluate a one-week oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria - oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria
EUCTR2004-003734-34-BE / Unknown statusNot Applicable
A one-weel, randomized, double-blind, placebo-controlled pilot trial to evaluate oral R129160 (60 mg b.i.d.) on the alleviation of itch in atopic dermatitis patients - Oral R129160 in atopic dermatitis
100 Clinical Results associated with Vapitadine Hydrochloride
Login to view more data
100 Translational Medicine associated with Vapitadine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Vapitadine Hydrochloride
Login to view more data
100 Deals associated with Vapitadine Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
---
DB05738

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic UrticariaPhase 2
EU
Stiefel Laboratories, Inc.Stiefel Laboratories, Inc.
-
Dermatitis, AtopicPhase 2-
Johnson & JohnsonJohnson & Johnson
-
PruritusPhase 2
BE
Stiefel Laboratories, Inc.Stiefel Laboratories, Inc.
-
PruritusPhase 2
CZ
Stiefel Laboratories, Inc.Stiefel Laboratories, Inc.
-
Dermatitis, AtopicDiscovery-
GSK PlcGSK Plc
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free